Mexican Consulate's Ventanilla de Salud (VDS)
New York, 10016, United States
Location status: Recruiting
NCT Number: NCT05770570
The researchers will conduct 'Taxi ROADmAP (Realizing Optimization Around Diet And Physical activity)', which also utilizes MOST, and the same 4 obesity intervention components as in SANOS, but targets the overweight/obesity crisis in another at-risk, low socioeconomic status (SES) population, taxi and for-hire vehicle (FHV) drivers (Lyft, Uber, etc.). ROADMAP also utilizes an effectiveness- implementation hybrid type 1 design. Hybrid trials, which blend effectiveness and implementation studies, can lead to more rapid translational uptake and more effective implementation. Taxi and FHV drivers are a growing, multilingual, hard-to-reach, predominantly immigrant and minority essential worker population. There are over 750,000 licensed taxi and FHV drivers in in the U.S. and over 185,000 in New York City (NYC). They have higher rates of overweight/obese range body mass index (BMI) than New Yorkers in general (77% vs 56%) and have high rates of elevated waist circumference, sedentary behavior, poor diets, and health care services underutilization. ROADmAP will test 4 evidence- and theory-based (Social Cognitive Theory [SCT]) behavior change intervention components. We will use MOST to identify which of the 4 components contribute most significantly and cost-effectively to weight loss among NYC drivers recruited at workplace health fairs (HFs) and virtually. Objectives are to apply MOST to design an optimized version of a scalable, lifestyle intervention for taxi/FHV drivers, and then to conduct a mixed methods multistakeholder process evaluation to facilitate widespread intervention implementation.
Interested in participating?
Request Info21 year and older
All sexes
Interventional
Phase 2
New York, 10016, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For COMIDA participants only:
For SANOS focus group participants only:
For SANOS RCT participants only:
For Family COMIDA participants only:
For ROADmAP RCT participants only:
For ROADmAP Phase 2 participants only:
Exclusion criteria
For COMIDA participants only:
For SANOS focus group participants only:
For SANOS RCT participants only:
For Family COMIDA participants only:
For ROADmAP RCT participants only:
In-person individual diet and physical activity (PA) counseling
Thrice-weekly diet/physical activity(PA) text messages
Weekly telephone support
Self-monitoring tools
Time frame: 12-months post-intake
Efficacy of intervention is achieved when participants have weight loss with a minimum threshold of 5% of overall body weight lost
Intervention components include:
Time frame: Up to 6 months
Costs associated with each component include: 1) In-person counseling: personnel time, participant travel time, text messaging services; 3) Telephone support: personnel time; 4) Self-monitoring tools: food diaries and digital scales.
Time frame: Up to 12 months
The ROADmAP Process Evaluation Questionnaire will be administered to all participants to gather data on implementation potential. Questions are on a Likert scale and will collect intervention delivery facilitators and barriers, intervention sustainability facilitators and barriers post-study completion. Feasibility will be indicated by extreme Likert scores (Strongly Agree, Neutral, Strongly Disagree).
Contact information is provided by the study sponsor or research team.
Francesca Gany, MD, MS
CONTACT
Jennifer Leng, MD,MPH
CONTACT
Memorial Sloan Kettering Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05144737
Body Weight, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT05874726
Apnea, Body Weight
Boston, Massachusetts, United States
View Trial DetailsNCT04110717
Body Weight, Glucose Metabolism Disorders
Dublin, Ireland
View Trial DetailsNCT07575932
Body Weight, Nutrition Disorders
Chandler, Arizona, United States
View Trial Details